In the initial test of the Salk vaccine for polio, 400,000 children were selected and divided into two groups of 200,000. One group was vaccinated with the Salk vaccine while the second group was vaccinated with a placebo. Of those vaccinated with the Salk vaccine, 33 later developed polio. Of those receiving the placebo, 115 later developed polio. Test the claim that the Salk vaccine is effective in lowering the polio rate. Use α= 0.01.

In the initial test of the Salk vaccine for polio, 400,000 children were selected and divided into two groups of 200,000. One group was vaccinated with the Salk vaccine while the second group was vaccinated with a placebo. Of those vaccinated with the Salk vaccine, 33 later developed polio. Of those receiving the placebo, 115 later developed polio. Test the claim that the Salk vaccine is effective in lowering the polio rate. Use α= 0.01.

Holt Mcdougal Larson Pre-algebra: Student Edition 2012

1st Edition

ISBN:9780547587776

Author:HOLT MCDOUGAL

Publisher:HOLT MCDOUGAL

Chapter11: Data Analysis And Probability

Section: Chapter Questions

Problem 8CR

See similar textbooks

Similar questions

What is an experiment?
What is meant by the sample space of an experiment?
Echinacea is widely used as an herbal remedy for the common cold, but does it work? In a double-blind experiment, healthy volunteers agreed to be exposed to common-cold-causing rhinovirus type 39 and have their symptoms monitored. The volunteers were randomly assigned to take either a placebo or an echinacea supplement daily for 5 days following viral exposure. Among the 103 subjects taking a placebo, 88 developed a cold, whereas 44 of the 48 subjects taking echinacea 1 developed a cold.
Most cases of cervical cancer are linked to a few strains of the human papilloma virus (HPV). The pharmaceutical company Merck developed a vaccine (Gardisil) against these HPV strains. Worldwide clinical trials followed young women after vaccination or administration of placebo for two to four years for signs of HPV-caused cervical cancer. Based on a sample of 100 women in the Gardisil group, 26% developed cervical cancer, and based on a sample 100 women in the placebo group, 32% developed cervical cancer. Test the claim that the proportion of women who developed cervical cancer in the Gardisil group is less than the proportion of women who developed cervical cancer in the placebo group at a = 0.05. Round your answers to three decimal places, and round any interim calculations to four decimal places. Fill in the hypotheses below where p₁ denotes the proportion of women who developed cervical cancer in the Gardisil group and p2 denotes the proportion of women who developed cervical…
Most cases of cervical cancer are linked to a few strains of the human papilloma virus (HPV). The pharmaceutical company Merck developed a vaccine (Gardisil) against these HPV strains. Worldwide clinical trials followed young women after vaccination or administration of placebo for two to four years for signs of HPV-caused cervical cancer. Based on a sample of 100 women in the Gardisil group, 26% developed cervical cancer, and based on a sample of 100 women in the placebo group, 32% developed cervical cancer. Test the claim that the proportion of women who developed cervical cancer in the Gardisil group is less than the proportion of women who developed cervical cancer in the placebo group at a = 0.05. Round your answers to three decimal places, and round any interim calculations to four decimal places. Fill in the hypotheses below where p₁ denotes the proportion of women who developed cervical cancer in the Gardisil group and p2 denotes the proportion of women who developed cervical…
Most cases of cervical cancer are linked to a few strains of the human papilloma virus (HPV). The pharmaceutical company Merck developed a vaccine (Gardisil) against these HPV strains. Worldwide clinical trials followed young women after vaccination or administration of placebo for two to four years for signs of HPV-caused cervical cancer. Based on a sample of 100 women in the Gardisil group, 26% developed cervical cancer, and based on a sample of 100 women in the placebo group, 32% developed cervical cancer. Test the claim that the proportion of women who developed cervical cancer in the Gardisil group is less than the proportion of women who developed cervical cancer in the placebo group at a = 0.05. Round your answers to three decimal places, and round any interim calculations to four decimal places. Fill in the hypotheses below where p₁ denotes the proportion of women who developed cervical cancer in the Gardisil group and p2 denotes the proportion of women who developed cervical…
Most cases of cervical cancer are linked to a few strains of the human papilloma virus (HPV). The pharmaceutical company Merck developed a vaccine (Gardisil) against these HPV strains. Worldwide clinical trials followed young women after vaccination or administration of placebo for two to four years for signs of HPV-caused cervical cancer. Based on a sample of 100 women in the Gardisil group, 34 % developed cervical cancer, and based on a sample of 100 women in the placebo group, 44 % developed cervical cancer. Test the claim that the proportion of women who developed cervical cancer in the Gardisil group is less than the proportion of women who developed cervical cancer in the placebo group at a = 0.05. Round your answers to three decimal places, and round any interim calculations to four decimal places. Fill in the hypotheses below where p₁ denotes the proportion of women who developed cervical cancer in the Gardisil group and p2 denotes the proportion of women who developed cervical…
Most cases of cervical cancer are linked to a few strains of the human papilloma virus (HPV). The pharmaceutical company Merck developed a vaccine (Gardisil) against these HPV strains. Worldwide clinical trials followed young women after vaccination or administration of placebo for two to four years for signs of HPV-caused cervical cancer. Based on a sample of 100 women in the Gardisil group, 24 % developed cervical cancer, and based on a sample of 100 women in the placebo group, 34 % developed cervical cancer. Test the claim that the proportion of women who developed cervical cancer in the Gardisil group is less than the proportion of women who developed cervical cancer in the placebo group at a = 0.10. Round your answers to three decimal places, and round any interim calculations to four decimal places. Fill in the hypotheses below where p₁ denotes the proportion of women who developed cervical cancer in the Gardisil group and p2 denotes the proportion of women who developed cervical…
Most cases of cervical cancer are linked to a few strains of the human papilloma virus (HPV). The pharmaceutical company Merck developed a vaccine (Gardisil) against these HPV strains. Worldwide clinical trials followed young women after vaccination or administration of placebo for two to four years for signs of HPV-caused cervical cancer. Based on a sample of 100 women in the Gardisil group, 34 % developed cervical cancer, and based on a sample of 100 women in the placebo group, 44% developed cervical cancer. Test the claim that the proportion of women who developed cervical cancer in the Gardisil group is less than the proportion of women who developed cervical cancer in the placebo group at a = 0.05. Round your answers to three decimal places, and round any interim calculations to four decimal places. Fill in the hypotheses below where p₁ denotes the proportion of women who developed cervical cancer in the Gardisil group and p2 denotes the proportion of women who developed cervical…
Individuals who have experienced a stroke are at an increased risk of having another stroke. Prevention is particularly important for high-risk populations. The Second European Stroke Prevention Study asked whether daily doses of an anti- blood-clotting agent, such as aspirin or dipyridamole, would help prevent strokes among patients who had just experienced a first stroke. Volunteer patients were randomly assigned to one of four treatment options: placebo, aspirin, Dipy., Both drugs. Researchers then recorded the patients who had another stroke and specifically if they died from that second stroke or not. Conduct the chi-square test of independence. What decision is made? Did not die from 2nd stroke 1447 1467 1466 1465 Died from 2nd stroke Placebo Aspirin Dipyr. Both drugs 202 182 188 185 Reject Ho. Fail to reject Ho.
Individuals who have experienced a stroke are at an increased risk of having another stroke. Prevention is particularly important for high-risk populations. The Second European Stroke Prevention Study asked whether daily doses of an anti-blood- clotting agent, such as aspirin or dipyridamole, would help prevent strokes among patients who had just experienced a first stroke. Volunteer patients were randomly assigned to one of four treatment options: placebo, aspirin, Dipy., Both drugs. Researchers then recorded the patients who had another stroke and specifically if they died from that second stroke or not. What are the hypotheses to determine if there is there a relationship between treatment and death from second stroke? Ho: Treatment type and death from second stroke are independent from one another. Ha: Treatment type and death from second stroke are NOT independent from one another. Ho: Treatment type and death from second stroke are NOT independent from one another. Ha: Treatment…
A drug company developed a honey-based liquid medicine designed to calm a child's cough at night. To test the drug, 105 children who were ill with an upper respiratory tract infection were randomly selected to participate in a clinical trial. The children were randomly divided into three groups - one group was given a dosage of the honey drug, the second was given a dosage of liquid DM (an over-the-counter cough medicine), and the third (control group) received a liquid placebo (no dosage at all). After administering the medicine to their coughing child, parents rated their children's cough diagnosis as either better or worse. The results are shown in the table below: Diagnosis Treatment Better Worse Total Control 4 33 37 DM 12 21 33 Honey 24 11 35 Total 40 65 105 In order to determine whether the treatment group is independent of the coughing diagnosis, a two-way chi-square test was conducted. 1. State the alternative and the null hypothesis. 2. Calculate test statistic 3. Determine…